INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 123 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $63 | -46.6% | 76,857 | +1.5% | 0.00% | -100.0% |
Q4 2022 | $118 | -99.9% | 75,743 | +1.3% | 0.00% | 0.0% |
Q3 2022 | $129,000 | +118.6% | 74,737 | +119.8% | 0.00% | – |
Q2 2022 | $59,000 | -61.9% | 34,008 | -21.3% | 0.00% | -100.0% |
Q1 2022 | $155,000 | -23.6% | 43,236 | +6.5% | 0.00% | 0.0% |
Q4 2021 | $203,000 | -14.7% | 40,585 | +21.9% | 0.00% | 0.0% |
Q3 2021 | $238,000 | -7.4% | 33,301 | +20.0% | 0.00% | 0.0% |
Q2 2021 | $257,000 | +16.8% | 27,753 | +17.1% | 0.00% | 0.0% |
Q1 2021 | $220,000 | +76.0% | 23,704 | +67.5% | 0.00% | 0.0% |
Q4 2020 | $125,000 | +119.3% | 14,151 | +38.9% | 0.00% | – |
Q3 2018 | $57,000 | -16.2% | 10,191 | -41.4% | 0.00% | – |
Q2 2018 | $68,000 | -23.6% | 17,398 | -8.4% | 0.00% | -100.0% |
Q1 2018 | $89,000 | -25.8% | 18,984 | -34.6% | 0.00% | 0.0% |
Q4 2017 | $120,000 | +37.9% | 29,030 | +207.6% | 0.00% | 0.0% |
Q2 2016 | $87,000 | +19.2% | 9,438 | +12.2% | 0.00% | – |
Q1 2016 | $73,000 | +73.8% | 8,412 | +34.0% | 0.00% | – |
Q4 2015 | $42,000 | -12.5% | 6,278 | -24.9% | 0.00% | – |
Q3 2015 | $48,000 | +128.6% | 8,364 | +228.3% | 0.00% | – |
Q2 2015 | $21,000 | +50.0% | 2,548 | +46.1% | 0.00% | – |
Q1 2015 | $14,000 | -12.5% | 1,744 | +0.3% | 0.00% | – |
Q4 2014 | $16,000 | – | 1,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|